Automatic control of arterial pressure after cardiac surgery. Evaluation of a microcomputer-based control system using glyceryl trinitrate and sodium nitroprusside

Comprehensive management of hypertensive emergencies and urgencies

Despite advances in chronic hypertension management, hypertensive emergencies and urgencies remain as serious complications. Much of this relates to poor compliance with effective antihypertensive management. Hypertensive emergencies and urgencies can also be seen as the initial manifestations of hypertension in pregnancy and in the perioperative period. Multiple classes of intravenous antihypertensive drugs are available to treat hypertensive emergencies, and specific agents may have an advantage in a given clinical situation. Orally active agents are used to treat hypertensive urgencies, and include clonidine, angiotensin-converting enzyme inhibitors, and labetalol. Most patients respond to drug therapy, but problems may arise related to a rapid normalization of blood pressure.

Computer control versus manual control of systemic hypertension during cardiac surgery

BACKGROUND

We recently demonstrated the feasibility of computer controlled infusion of vasoactive drugs for the control of systemic hypertension during cardiac surgery. The objective of the current study was to investigate the effects of computer controlled blood pressures on hemodynamic stability when compared to conventional manual control.

METHOD

Systemic artery blood pressures were managed either by computer (80 patients) or by a well-trained anesthesiologist (80 patients). The vasodilator drugs sodium nitroprusside and nitroglycerin were used. Hemodynamic stability was determined from the standard deviation of the mean arterial pressure samples and from the percentages of time that arterial pressure was hypertensive or hypotensive.

RESULTS

The average standard deviation of the mean arterial pressure samples was smaller for the computer controlled than for the manually controlled group: 7.5+/-2.2 (mean+/-SD) versus 8.9+/-2.3 mmHg (P<0.0001). The systemic artery pressure was less hypertensive and less hypotensive in the computer controlled than in the manually controlled group: 9.4+/-5.7 versus 13.1+/-6.0% (P<0.0001) and 8.0+/-5.9 versus 11.8+/-7.4% (P<0.0001), respectively.

CONCLUSION

We conclude that, compared with manual control, computer control of systemic hypertension significantly improved hemodynamic stability during cardiac surgery.

Treatment of hypertension in the perioperative patient

OBJECTIVE

To review studies and drug therapy relating to the treatment of hypertension in perioperative patients.

DATA SOURCES

Articles were selected from a MEDLINE search (1966-August 1998), and several textbooks on hypertension and surgery were reviewed. In addition, bibliographies of all articles and textbook chapters were studied for articles not found in the computerized searches.

STUDY SELECTION

Clinical studies involving hypertension in the perioperative setting were included. The initial search was limited to studies conducted in humans and published in English.

DATA EXTRACTION

Information regarding drug therapy was reviewed and guidelines were constructed for managing surgical patients with acute blood pressure elevations.

DATA SYNTHESIS

Although nitroprusside and nitroglycerin, with their short onset of action and duration of effect, are indicated for hypertensive emergencies, a variety of agents are available for hypertensive urgencies. An algorithm that can be used as a template for the development of intrainstitutional guidelines is provided.

CONCLUSIONS

Due to the scarcity of comparative trials, decisions involving agents for the treatment of perioperative hypertension must often be made based on combined efficacy, toxicity, cost, and convenience considerations.

Feedback control of anaesthesia

Feedback control of anaesthesia can improve the quality of patient care while reducing the administration and cost of anaesthetic drugs. Systems have been available for several years to control blood pressure and neuromuscular blockade. Control of anaesthetic depth has been reported using the median frequency of the electroencephalogram. Recently, the monitoring of anaesthetic depth using the bispectral index or auditory evoked potentials has greatly improved feedback control of the depth of anaesthesia.

Feedback control in anaesthesia

This review considers the some of the methods of automatic control which are usable in medicine. The features of each type of control system are explained and the advantages and disadvantages summarised. The author has attempted to maintain a balance between what is possible with the excellence of modern engineering, and what is feasible in the clinical area, and practical when working with patients. The problem of lack of knowledge of an individual patient is emphasised, as is the potential of fuzzy logic methods in the future.

Correction for respiration artifact in pulmonary blood pressure signals of ventilated patients

OBJECTIVE

To develop an algorithm that corrects pulmonary artery pressure signals of ventilated patients for the respiration artifact. The algorithm should test the validity of the pulmonary pressure signal and differentiate between the cyclic respiration artifact and true measurement artifacts.

METHODS

The shape of each pulmonary pressure beat is described by eight characteristic features, including mean pressure value and the systolic and diastolic timing and pressure values. The features are corrected for the respiration artifact by fitting them in a least-squares sense on the first and second harmonics of the ventilator frequency. The corrected features are used by a signal validation algorithm, which adds a validity flag to each pressure beat. The validation algorithm rejects pressure beats with sudden changes in their shape but adapts itself when the changes persist.

RESULTS

The performance of the correction and validation technique was evaluated using pulmonary artery pressure signals of 30 patients who were scheduled for open heart surgery. The algorithm correctly recognized as invalid data those pressure signals disturbed by coagulation, surgical manipulations, or flushes of the pressure line. The algorithm marked on average 77 +/- 11% of the pulmonary pressure beats as valid.

CONCLUSIONS

The validation algorithm marked sufficient pressure beats as valid to update a trend display every 5 sec. The correction algorithm enabled the validation algorithm to differentiate between true measurement artifacts and the respiration artifact.

Automated infusion of nitroglycerin to control arterial hypertension during cardiac surgery

OBJECTIVE

To evaluate the feasibility of closed-loop blood pressure control during cardiac surgery.

DESIGN

A closed-loop system regulated peroperative hypertension by controlling the infusion rate of the vasodilator nitroglycerin (NTG). The controller consisted of a regulator which was monitored by a supervisory computer program. Mean arterial pressure (MAP) was calculated every 5 s from measurements of the radial artery pressure signal. The regulator calculated an NTG infusion rate with each new MAP measurement. The supervisory computer program monitored the regulator's actions and adapted or overruled the regulator when required.

SETTING

The cardiac surgery operating room.

PATIENTS

46 patients who were scheduled for cardiac surgery and who developed peroperative hypertension.

INTERVENTIONS

Patients were scheduled for either bypass or valve replacement surgery. The closed-loop system was used to control hypertension before and after cardiopulmonary bypass. The use of the closed-loop system did not require deviation from the protocol normally used during cardiac surgery. All patients received standard continuous anaesthesia with opioids.

MEASUREMENTS AND RESULTS

Initial automatic control was achieved in 9.4 (4.1 SD) min. The percentage of time that MAP remained in a range around the target MAP of +/- 10 and +/- 20 mmHg was 74 and 94%, respectively. The mean NTG infusion rate while MAP was within 5 mmHg of target MAP was 1.14 (0.84 SD) micrograms kg-1 min-1. Target MAP was set between 65 and 90 mmHg. There was a small group of patients (6 out of 46) who did not respond to NTG and required alternative drug therapy.

CONCLUSIONS

The controller provided fast and stable control in all patients. The expert knowledge implemented through the supervisory computer program enabled the controller to respond adequately to the rapid changes in arterial pressures commonly associated with cardiac surgery. We conclude that closed-loop control of arterial pressure is feasible not only in the cardiac surgical care unit but also during cardiac surgery.

A model for technology assessment as applied to closed loop infusion systems. Technology Assessment Task Force of the Society of Critical Care Medicine

OBJECTIVES

To test a model for the assessment of critical care technology on closed loop infusion control, a technology that is in its early stages of development and testing on human subjects.

DATA SOURCES

A computer-assisted search of the English language literature and reviews of the gathered data by experts in the field of closed loop infusion control systems.

STUDY SELECTION

Studies relating to closed loop infusion control that addressed one or more of the questions contained in our technology assessment template were analyzed. Study design was not a factor in article selection. However, the lack of well-designed clinical outcome studies was an important factor in determining our conclusions.

DATA EXTRACTION

A focus person summarized the data from the selected studies that related to each of the assessment questions. The preliminary data summary developed by the focus person was further analyzed and refined by the task force. Experts in closed loop systems were then added to the group to review the summary provided by the task force. These experts' comments were considered by the task force and this final consensus report was developed.

DATA SYNTHESIS

Closed loop system control is a technological concept that may be applicable to several aspects of critical care practice. This is a technology in the early stages of evolution and much more research and data are needed before its introduction into usual clinical practice. Furthermore, each specific application and each device for each application (e.g., nitroprusside infusion, ventilator adjustment), although based on the same technological concept, are sufficiently different in terms of hardware and computer algorithms to require independent validation studies.

CONCLUSIONS

Closed loop infusion systems may have a role in critical care practice. However, for most applications, further development is required to move this technology from the innovation phase to the point where it can be evaluated so that its role in critical car practice can be defined. Each application of closed loop infusion systems must be independently validated by appropriately designed research studies. Users should be provided with the clinical parameters driving each closed loop system so that they can ensure that it agrees with their opinion of acceptable medical practice. Clinical researchers and leaders in industry should collaborate to perform the scientifically valid, outcome-based research that is necessary to evaluate the effect of this new technology. The original model we developed for technology assessment required the addition of several more questions to produce a complete analysis of an emerging technology. An emerging technology should be systematically assessed (using a model such as the model developed by the Society of Critical Care Medicine), before its introduction into clinical practice in order to provide a focus for human outcome validation trials and to minimize the possibility of widespread use of an unproven technology.

Management of hypertensive urgencies and emergencies

Hypertensive emergency is a condition in which there is elevation of both systolic and diastolic blood pressure with the presence of acute target organ disease. Hypertensive urgency is a condition where the blood pressure is elevated (diastolic > 120 mmHg) with the absence of acute target organ disease. Hypertensive emergencies are best managed with parenteral drugs and careful intraarterial blood pressure monitoring. Hydralazine has been widely used in treatment of hypertension in eclampsia and preeclampsia, and its safety has been demonstrated in these patients. Sodium nitroprusside (SNP) has the most reliable antihypertensive activity, which begins immediately after its administration and ends when the infusion is stopped. As with diazoxide, it should be used with caution in patients with impaired cerebral flow. SNP is the preferred drug in obtaining controlled hypotension in patients undergoing neurovascular surgery. Intravenous nitroglycerin is useful in patients prone to myocardial ischemia, but should be avoided in patients with increased intracranial pressure. Esmolol is effective in controlling both supraventricular tachyarrhythmias and severe hypertension. Its short onset of duration of action make it useful in the emergent setting, but because of its negative inotropic effect its use should be avoided in patients with low cardiac output. Verapamil should not be used in patients with preexisting conduction abnormalities. Nicardipine is a potent arteriolar vasodilator without a significant direct depressant effect on myocardium. As with other afterload reducing agents, it should not be used in patients with severe aortic stenosis. Because angiotensin-converting enzyme (ACE) inhibitors generally cause cerebral vasodilatation, enalaprilat may be particularly beneficial for patients who are at high risk of developing cerebral hypotensive episodes secondary to impaired cerebral circulation. Fenoldopam, a selective post-synaptic dopaminergic receptor (DA1) has been shown to be effective in treating severe hypertension with a lower incidence of side effects than SNP. Hypertensive urgencies can usually be managed with oral agents. Oral nifedipine, captopril, clonidine, labetalol, prazosin, and nimodipine have all been shown to be effective in these situations.

Evaluation of a long-range adaptive predictive controller for computerized drug delivery systems

A closed-loop adaptive control system, based on the generalized predictive control law with a terminal matching condition, has been developed for computerized drug delivery. The control law is a minimization of the squares of prediction errors over a small future prediction horizon plus weighted square of the prediction error at steady-state. A control-relevant, long-range identification algorithm is used for on-line parameter estimation. Since the control and identification are mutually compatible, the system truly satisfies the approximate dual control criterion. The system has been applied to the control of mean arterial pressure (MAP) by automatic infusion of sodium nitroprusside in the presence of physical and physiological constraints. Experimental evaluation on six mongrel dogs, in an ethics-approved manner, included setpoint tracking and regulation of MAP in the presence of unpredictable disturbances. The system was found to be capable of inducing hypotension in an average of 2.44 +/- 0.31 min (mean +/- standard error of mean) after probing without any overshoots in mean arterial pressure. The nitroprusside infusion was also free of any ringing. When the subjects were not disturbed, 96.2% of mean arterial pressure remained within 5 mm Hg of the target pressure. A series of disturbances introduced in the presence and absence of closed-loop control affirms the robustness and effectiveness of this control system.

Control strategies for arterial blood pressure regulation

This paper reviews the theoretical development of automatic control strategies for arterial blood pressure regulation. The literature is classified by control strategy. Proportional-integral-derivative controllers, optimal controllers, adaptive controllers, and rule-based controllers are the most commonly encountered strategies in the literature. A brief description of each control scheme is given, followed by examples of each from the literature. Validation methods for the control performance vary from computer simulations to clinical tests on human patients. A number of reports of clinical success support the feasibility of advanced control systems in this problem. Issues on control systems in the clinical environment are also discussed.

Closed loop control of arterial hypertension following intracranial surgery using sodium nitroprusside. A comparison of intra-operative halothane or isoflurane

Forty patients were chosen at random to receive halothane or isoflurane anaesthesia during craniotomy and a comparison of the postoperative hypertensive response was made using a microcomputer-based closed-loop arterial pressure control system with sodium nitroprusside to control and assess arterial pressure during the first 6 postoperative hours. A desired target systolic pressure was chosen for each patient and the frequency of hypertension, sodium nitroprusside requirements and quality of arterial pressure control were compared between the two groups. Thirty-five patients required sodium nitroprusside. The halothane group required a median dose of 15.2 mg (range 0-72) compared to 3.4 mg (range 0-87) in the isoflurane group. This difference is not statistically significant. Quality of arterial pressure control was satisfactory in both groups. In conclusion, arterial hypertension occurs frequently following intracranial surgery and is uninfluenced by the choice of halothane or isoflurane intra-operatively. This closed-loop arterial pressure control system functioned safely and effectively in this context.

Designing an outcome-oriented computer decision-support system for cardiovascular ICU--a preliminary report

This paper describes the conceptual framework and preliminary results of an outcome-oriented decision-support system prototype for the cardiovascular intensive care unit (CVICU). The major characteristics of this design include: (1) its problem-based approach to solving clinical problems; (2) an integrated structure with the hospital information system in terms of its data, model and knowledge bases; (3) proposed alternative modes of interaction that include monitoring and critiquing; (4) and research modules that design, manage, and analyze outcome-based clinical studies. At present, an initial prototype has been implemented on a PC as a set of modules accessible from a main menu. The structural framework of the overall system is fairly well defined but only limited quantitative, statistical and expert knowledge has been captured. The second phase of the project involves porting the prototype to a Unix workstation environment, refining and adding models to the model base, expanding its knowledge bases, reasoning capability, and testing the prototype with actual clinical cases in a real-time fashion.

The Ohmeda 9000 syringe pump. The first of a new generation of syringe drivers

The Ohmeda 9000 syringe pump was developed in response to the need for an infusion apparatus to administer intravenous anaesthetic agents. It incorporates a bolus facility for the rapid, controlled delivery of loading infusions, or incremental dosing over a background maintenance infusion, and may be interfaced with a controller for computer-driven infusions. The Ohmeda 9000 pump has undergone bench testing and detailed evaluation in clinical practice using a variety of syringe sizes and makes. It is capable of accurate delivery over a range of infusion rates provided the recommended manufacturers' syringes are used with the appropriate pump setting. The pump was easy to use and reliable in clinical research and routine clinical practice. It should find its niche as the first genuinely 'anaesthetist-friendly' infusion pump.

Rapid-acting parenteral antihypertensive agents

Parenteral antihypertensive agents are useful in those clinical situations where rapid reduction of blood pressure is necessary or where treatment with oral antihypertensive medications is not feasible. Given the diverse selection of parenteral antihypertensive drugs now available, therapy can be individualized. The presence of concurrent diseases will often influence the decision-making process regarding choice of an agent. Complications of parenteral antihypertensive therapy can arise from the intrinsic properties of the various drugs or the development of severe hypotension. Gradual lowering of blood pressure, in conjunction with careful clinical evaluation, will minimize the risks of acute parenteral antihypertensive therapy. Given that parenteral antihypertensive therapy often needs to be replaced by oral therapy, those drugs that can be used both parenterally and orally may have an advantage.

Development and evaluation of a dual-pump microcomputer-based closed-loop arterial pressure control system

Hypertension after cardiac surgery is common and is associated with increased morbidity. It is usually managed by the infusion of short acting vasodilators. The use of a closed-loop computer system to control the infusion of a vasodilator has been shown to compare favourably with manual control. We have developed a closed-loop system for the ATARI 1040ST microcomputer to control arterial pressure by the simultaneous infusion of two vasodilators. The control program is based on a proportional-integral-derivative algorithm which has been adapted to allow control of two IMED 929 infusion pumps from one RS-232 port. All communication between the user and computer is carried out with a 'mouse', thus increasing acceptability of the system to ward staff. Cardiovascular data are collected on-line from the patient monitor via a custom-built analogue to digital convertor. This system was used to study glyceryl trinitrate and sodium nitroprusside in 24 patients requiring vasodilators after cardiopulmonary bypass. The study showed that in 14 of the patients hypertension was controlled by GTN alone and 10 required supplementary SNP. We have demonstrated that this dual-pump automatic arterial pressure control system is a satisfactory and safe method of administering two vasodilators simultaneously. It is suitable for both routine clinical and research uses.